| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |